New York Presbyterian Queens — Flushing, New York

New York Presbyterian Queens is a clinical research site located in Flushing, New York, United States 11355.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Presbyterian Queens has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Proteinuric Kidney Disease, Squamous Cell Carcinoma (SCC).

Sponsors: Novartis Pharmaceuticals, Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Presbyterian Queens?

New York Presbyterian Queens has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Presbyterian Queens conducted?

New York Presbyterian Queens has 10 clinical trials on record, with 3 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Proteinuric Kidney Disease, Squamous Cell Carcinoma (SCC).

Is New York Presbyterian Queens accredited by Crixeo Health?

Yes — New York Presbyterian Queens holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York Presbyterian Queens?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.